COMMUNIQUÉS West-GlobeNewswire

Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update
09/03/2026
- Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and the first brain [...]
Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026
09/03/2026
WOBURN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
09/03/2026
Webcast Scheduled for Monday, March 16 at 8:30 a.m. Eastern CHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated injectables contract development [...]
Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
09/03/2026
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/03/2026
WATERTOWN, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
CapsoVision to Participate in the 38th Annual ROTH Conference
09/03/2026
- Company to participate in a fireside chat and 1x1 investor meetings on March 23, 2026 - SARATOGA, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology [...]
Slim Force BHB Ketone Claims Evaluated: 2026 Consumer Research Report on SlimForce Ingredients, Ketogenic Supplement Positioning, and What Adults Should Verify Before Purchasing
09/03/2026
An informational 2026 consumer research report examining Slim Force exogenous ketone formulation, BHB salt research context, proprietary blend transparency, pricing disclosures, and verification considerations for [...]
Dianthus Therapeutics, Inc. Announces Proposed $400 Million Underwritten Public Offering
09/03/2026
NEW YORK and WALTHAM, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus” or the “Company”), a clinical-stage biotechnology company dedicated to developing next-generation [...]
COVID mRNA Vaccines May Alter Gene Expression, according to Journal of American Physicians and Surgeons
09/03/2026
TUSCON, Ariz., March 09, 2026 (GLOBE NEWSWIRE) -- The mechanism of action of mRNA vaccines goes far beyond harnessing host cellular machinery to produce antigenic proteins to spur immunity, write Nicolas Hulscher , M.P. [...]
Novonesis named a Great Employer to Work For in North Carolina
09/03/2026
Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- Novonesis , a global leader in biosolutions, has been named a 2026 Great Employer to Work for in North Carolina by Best Companies Group (BCG), marking the [...]
Kristen Boehmer of Empowered Lyfe Partners with MD Logic Health to Launch Daily Colostrum, an Advanced Low Molecular Weight Bioactive Colostrum
09/03/2026
Miami, FL, March 09, 2026 (GLOBE NEWSWIRE) -- As consumer awareness surrounding the connection between gut health and overall wellness continues to rise, demand for simple, high-quality, science-backed solutions is [...]
Update: Ipsen retire volontairement Tazverik® (tazemetostat) dans le traitement du lymphome folliculaire et du sarcome épithélioïde
09/03/2026
PARIS, FRANCE, 09 mars 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) annonce aujourd'hui le retrait volontaire de Tazverik ® (tazemetostat) des marchés où il est commercialisé par Ipsen, et dans toutes les indications. La [...]
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma
09/03/2026
PARIS, FRANCE, 09 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik ® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is [...]
Choice Healthcare Services Announces Expansion of Children’s Choice Pediatric Dentistry Locations in California
09/03/2026
Two Locations to Launch New, Enhanced Offices in 2026 for Greater Patient Comfort and Accessibility Sacramento, CA, March 09, 2026 (GLOBE NEWSWIRE) -- Choice Healthcare Services , the parent company of Children’s Choice [...]
VisiFlora Gut-Eye Vision Support Claims Examined: 2026 Consumer Report on the 22-Ingredient Formula, Gut-Eye Axis Research, and What Adults Researching Vision Supplements Should Verify
09/03/2026
A 2026 informational consumer research report examining VisiFlora's gut-eye axis positioning, ingredient research context, 22-ingredient formula structure, pricing disclosures, and independent verification [...]
MemoTril Consumer Concerns Under Investigation: Critiquing The Memo Tril Claims
09/03/2026
A 2026 consumer research report examining MemoTril marketing claims, ingredient transparency, refund policies, manufacturing disclosures, and verification considerations for adults researching cognitive support [...]
The Great Give Back brings community together in support of Royal Columbian Hospital
09/03/2026
NEW WESTMINSTER, British Columbia, March 09, 2026 (GLOBE NEWSWIRE) -- Royal Columbian Hospital Foundation is inviting the community to come together for The Great Give Back, presented by Pan American Silver , a free, [...]
FocusMax Cognitive Support Claims Evaluated: Latest 2026 Consumer Research Report on FocusMax Ingredients, Proprietary Blend Dosing, and Cognitive Supplement Research
09/03/2026
A 2026 informational consumer research report examining FocusMax cognitive support marketing claims, ingredient-level research context, proprietary blend transparency, pricing disclosures, and verification [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
09/03/2026
Please see enclosed pdf. Attachment 09032026_trading_in_shares_NBC

Pages